<--- Back to Details
First PageDocument Content
Clinical research / Drug safety / European Medicines Agency / Pharmaceutical industry / Pharmacovigilance / Pharmacoepidemiology / EMA / Agency of the European Union / Health technology assessment / Pharmaceutical sciences / Pharmacology / Medicine
Date: 2015-04-27 04:26:27
Clinical research
Drug safety
European Medicines Agency
Pharmaceutical industry
Pharmacovigilance
Pharmacoepidemiology
EMA
Agency of the European Union
Health technology assessment
Pharmaceutical sciences
Pharmacology
Medicine

ENCePP Work Plan

Add to Reading List

Source URL: www.encepp.eu

Download Document from Source Website

File Size: 284,37 KB

Share Document on Facebook

Similar Documents

PORTAL Program on Regulation, Therapeutics, And Law Division of Pharmacoepidemiology and Pharmacoeconomics Harvard Medical School and Brigham & Women’s Hospital

DocID: 1unul - View Document

Opioids, Aspirin, NSAIDs, sCOX-2 Inhibitors & Breast Cancer Recurrence: Pharmacoepidemiology studies using DBCG data Deirdre Cronin Fenton Associate Professor, Ph.D.

DocID: 1s8CN - View Document

Amphetamine / Methylphenidate / Attention deficit hyperactivity disorder / Euphoriants / Stimulants / Attention deficit hyperactivity disorder management / Lisdexamfetamine / Dextroamphetamine / Prescription drug / Adult attention deficit hyperactivity disorder / Pemoline / Medical prescription

prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORT

DocID: 1pBj0 - View Document

Epidemiology / Pharmacoepidemiology / Pharmacology / Boehringer Ingelheim / McGill University

Microsoft Word - Program_2011_v3.docx

DocID: 1oyUA - View Document

pharmacoepidemiology and drug safety (in press) Published online in Wiley InterScience (www.interscience.wiley.com). DOI: pds.980 ORIGINAL REPORT An analysis of the significant variation in psychostimulant use ac

DocID: 1kCxI - View Document